BAG3-DCM Natural History Study

Sponsor
Rocket Pharmaceuticals Inc.
Study ID
NCT07486752
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Cardiovascular Diseases
  • Dilated Cardiomyopathy (DCM)
  • Genetic Diseases
  • Heart Diseases

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The goal of this international observational study is to learn about the natural history of Dilated Cardiomyopathy (DCM) arising from pathogenic BAG3 variants in adult patients ≥18 years of age.

Key Dates

First listed
Mar 20, 2026
Start date
May 31, 2026
Status verified
Mar 2026
Primary completion
Dec 31, 2032
Completion
Mar 31, 2033

Study Design

Enrollment
30 participants (estimated)

Arms

  • Arm: Prospective Cohort and Retrospective (Non Interventional)

Primary Outcome Measure

Cardiac structure and function [ Time Frame: 48 months ]

Central Contacts

Related Studies